{{medical}}
{{drugbox
| verifiedrevid = 408987039
|IUPAC_name= (2''S'')-2-[(2''R'')-2-benzyl-3-(2-methylpropane-2-sulfonyl)propanamido]-''N''-[(2''R'',3''S'',4''R'')-1-cyclohexyl-4-cyclopropyl-3,4-dihydroxybutan-2-yl]-3-(1''H''-imidazol-4-yl)propanamide
|image=Remikiren.svg
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4884377
| InChI = 1/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25-,27+,28+,29+,30-/m1/s1
| InChIKey = UXIGZRQVLGFTOU-VQXQMPIVBV
| smiles = O=S(=O)(C(C)(C)C)C[C@H](C(=O)N[C@H](C(=O)N[C@@H](CC1CCCCC1)[C@@H](O)[C@@H](O)C2CC2)Cc3cncn3)Cc4ccccc4
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 31601
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25-,27+,28+,29+,30-/m1/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = UXIGZRQVLGFTOU-VQXQMPIVSA-N
| InChI1 = 1S/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25-,27+,28+,29+,30-/m1/s1
| InChIKey1 = UXIGZRQVLGFTOU-VQXQMPIVSA-N
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number=126222-34-2
|ATC_prefix=C09
|ATC_suffix=XA01
|ATC_supplemental=
|PubChem = 6324659
|DrugBank=APRD00163
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D09038
|C=33|H=50|N=4|O=6|S=1
|molecular_weight=630.839 g/mol
|bioavailability=
|protein_bound=83%
|metabolism=
|elimination_half-life=
|excretion=
|pregnancy_AU=<!-- A / B1 / B2 / B3 / C / D / X -->
|pregnancy_US=<!-- A / B / C / D / X -->
|pregnancy_category=
|legal_AU=<!-- Unscheduled / S2 / S4 / S8 -->
|legal_UK=<!-- GSL / P / POM / CD -->
|legal_US=<!-- OTC / Rx-only -->
|legal_status=
|routes_of_administration=
}}
'''雷米克仑'''（{{lang-en|Remikiren}}）是一款用于抗[[高血压|高血压]]的[[肾素抑制剂|肾素抑制剂]]。它由[[罗氏|罗氏制药]]首先于1996年推出。<ref>{{cite journal |author=Richter WF, Whitby BR, Chou RC |title=Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals |journal=Xenobiotica |volume=26 |issue=3 |pages=243–54 |year=1996 |pmid=8730917 |doi=10.3109/00498259609046705}}</ref>

==参考资料==
{{reflist}}

{{基于肾素-血管紧张素系统的抗高血压药}}

[[Category:抗高血压药物|L雷]]